Clinical Trial Update: Long-term, Open-label Follow-up Treatment of Patients With A-fib Who Have Been Previously Treated With BIBR 1048 [Phase 2]

View source ↗

Summary

Long-term, open-label follow-up data are being reported for atrial fibrillation patients who were previously treated with BIBR 1048 in a Phase 2 trial. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Stroke

Drugs mentioned

• BIBR 1048

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Atrial Fibrillation, Stroke | Phase 2 | Status: TERMINATED | Results posted: 2011-02-03